A detailed history of Sugarloaf Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sugarloaf Wealth Management, LLC holds 2,975 shares of ABBV stock, worth $506,791. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,975
Previous 2,967 0.27%
Holding current value
$506,791
Previous $508,000 15.55%
% of portfolio
0.12%
Previous 0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$163.84 - $199.33 $1,310 - $1,594
8 Added 0.27%
2,975 $587,000
Q2 2024

Jul 08, 2024

BUY
$154.79 - $180.76 $1,393 - $1,626
9 Added 0.3%
2,967 $508,000
Q1 2024

Apr 23, 2024

SELL
$159.82 - $182.1 $11,507 - $13,111
-72 Reduced 2.38%
2,958 $538,000
Q4 2023

Jan 10, 2024

BUY
$137.6 - $154.97 $39,353 - $44,321
286 Added 10.42%
3,030 $469,000
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $77,749 - $90,006
-582 Reduced 17.5%
2,744 $409,000
Q2 2023

Jul 13, 2023

SELL
$132.51 - $164.9 $261,972 - $326,007
-1,977 Reduced 37.28%
3,326 $448,000
Q1 2023

Apr 26, 2023

SELL
$144.61 - $166.54 $226,025 - $260,302
-1,563 Reduced 22.76%
5,303 $845,000
Q4 2022

Feb 03, 2023

SELL
$138.31 - $165.87 $194,048 - $232,715
-1,403 Reduced 16.97%
6,866 $1.11 Million
Q3 2022

Oct 11, 2022

BUY
$134.21 - $153.93 $37,176 - $42,638
277 Added 3.47%
8,269 $1.11 Million
Q2 2022

Jul 12, 2022

SELL
$137.62 - $174.96 $963 - $1,224
-7 Reduced 0.09%
7,992 $1.22 Million
Q1 2022

Apr 25, 2022

BUY
$131.98 - $163.75 $7,522 - $9,333
57 Added 0.72%
7,999 $1.3 Million
Q4 2021

Jan 20, 2022

BUY
$107.43 - $135.93 $6,768 - $8,563
63 Added 0.8%
7,942 $1.08 Million
Q3 2021

Oct 20, 2021

BUY
$106.4 - $120.78 $67,457 - $76,574
634 Added 8.75%
7,879 $850,000
Q2 2021

Jul 20, 2021

BUY
$105.21 - $117.21 $6,102 - $6,798
58 Added 0.81%
7,245 $816,000
Q1 2021

Apr 19, 2021

BUY
$102.3 - $112.62 $60,868 - $67,008
595 Added 9.03%
7,187 $778,000
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $44,028 - $59,442
547 Added 9.05%
6,592 $736,000
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $23,882 - $28,030
278 Added 4.82%
6,045 $529,000
Q2 2020

Jul 21, 2020

BUY
$73.37 - $98.18 $75,497 - $101,027
1,029 Added 21.72%
5,767 $566,000
Q1 2020

Apr 15, 2020

BUY
$64.5 - $97.79 $17,157 - $26,012
266 Added 5.95%
4,738 $361,000
Q4 2019

Jan 29, 2020

BUY
$72.13 - $90.25 $322,565 - $403,598
4,472 New
4,472 $396,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sugarloaf Wealth Management, LLC Portfolio

Follow Sugarloaf Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.